LemaA.01332.a
aspartate carbamoyltransferase, putative
CENTER ID:
LemaA.01332.a
ORGANISM:
Leishmania major Friedlin
ASSOCIATED DISEASE:
Cutaneous leishmaniasis
CURRENT STATUS:
in PDB
COMMUNITY REQUEST:
True
NIH RISK GROUP:
2
SELECT AGENT:
False
NIH PRIORITY
pathogens category:
unclassified
Ordering Clones & Proteins
If there are materials available for this target, they will be listed below.
Materials can be ordered from SSGCID using the button in the "order material" column.
Clicking the button will add the material to a virtual cart.
You may order multiple materials at a time at no cost to you, as this contract is funded
by NIAID. When you are ready to place your order, click the "Place Order" link which will
appear in the top right corner of the page after you place your first item in your cart.
Clones*
CENTER
REFERENCE ID
DOMAIN/REGION
DESCRIPTION
INFO
AA
START
AA
STOP
ORDER
MATERIAL
LemaA.01332.a.AE1.GE43228
full length
info
1
327
LemaA.01332.a.AE1.GE43228
LemaA.01332.a.B1.GE34407
full length
info
1
327
LemaA.01332.a.B1.GE34407
* SSGCID clones represent un-induced expression constructs which have been verified by sequencing from vector primers. Clones may contain a tag, such as N-term 6xHis . Get sequence information
using the button in the "info" column.
Proteins
CENTER REFERENCE ID
DOMAIN/REGION DESCRIPTION
INFO
AA START
AA STOP
ORDER MATERIAL
LemaA.01332.a.AE1.PS38618
full length
info
1
327
PS38618
LemaA.01332.a.AE1.PS38633
full length
info
1
327
PS38633
LemaA.01332.a.B1.PW35017
full length
info
1
327
PW35017
Structures
7K46
DEPOSITED: 9/14/2020
DETERMINATION: XRay
CLONE: LemaA.01332.a.AE1.GE43228
PROTEIN: LemaA.01332.a.AE1.PS38633
Sequences
These sequences are the native gene sequence; sequences of constructs derived from these sequences may differ due to codon optimization or other protocols.
To find the specific sequence of any material you may have ordered, click on the "info" button next to the name of that material.
AA Sequence
MPTFNPVASL KGQSVASAAQ FSRADIDALI QLALDMKTHI EAGKTIDTLR GRVMTPLFFE DSSRTLSSFC AAMMRLGGSV VNFKVETSSV NKGETLQDTI RTLDSYSDVL VLRHAKEEAL EQAMSVATHP IMNAGNGAGE HPTQALLDIL TIHAELGAVD GIAIALIGDL KKGRTVHSLL KLLAHNFALR KVYLIAPAGL EMPAEVLEHV ATDVVKRGIA IQQASGLTPE IVADCDVLYA TRLQKERFVA SAAGDADALT AFEASKASLL IDKARLAHAK AKMVVMHPLP RVDELSTDID DDPRAAYFRQ MRYGLFMRMA ILFSVLS
NT Sequence
atgcccacct tcaacccggt cgcctccctc aagggccaga gtgtggcctc cgctgcgcag ttctcgcgcg ctgacatcga cgccctcatc cagctcgcac tcgatatgaa gacacacatc gaggcaggga aaacgatcga caccctgcgc ggccgcgtca tgacgccgct gttcttcgag gacagctctc gcacgctgtc gagtttttgc gcggccatga tgcggctggg cggcagcgtc gtgaacttca aggtggagac gtcgtctgtg aacaagggtg aaacgctgca ggacaccatt cgcacgctgg actcgtacag tgacgtgctc gtgctccgcc acgctaagga ggaagcgctg gagcaggcga tgagtgtggc aacgcacccg atcatgaacg ccggcaacgg cgctggtgag cacccgactc aggcgttgct cgacatcctc acgattcacg ccgagctcgg cgccgtggac ggcattgcga tcgcgttgat cggggacctc aagaagggcc gcacggtgca ttcgctgctg aagctgctgg cgcacaactt cgcgctgagg aaggtgtacc tcatcgcccc cgcggggctg gagatgccgg cggaggtgct ggagcatgtc gcgacggacg tggtgaagcg cgggatcgcg attcagcagg cgtccggcct cactcctgag attgtggccg actgcgacgt gctctacgcg acgcgcctgc agaaggagcg ctttgttgcc tccgctgccg gtgacgccga cgccctgacc gcctttgagg cttctaaagc gagcctgctg atcgacaagg ctcgcctggc acacgcgaag gcgaagatgg ttgtcatgca cccgctgcct cgcgtggatg agctcagcac cgacattgac gacgacccgc gtgcggcgta tttccgacag atgcgctacg gcctcttcat gcgcatggct atcctcttca gcgtgctttc ttga
Details for LemaA.01332.a.AE1.GE43228
HARVESTED ON:
6/12/2019
SEQUENCED ON:
6/18/2019
EXPECTED MW:
36kDa
OBSERVED MW:
36kDa
ANTIBIOTIC MARKER:
ampicillin
COUNT OF EXPRESSION COLONIES:
Good (10-50)
TOTAL EXPRESSION LEVEL:
Low Expression
SOLUBLE EXPRESSION LEVEL
Moderate Expression
EXPRESSION HOST:
BL 21 (DE3) Rosetta
SEQUENCING RESULT:
PERCENT IDENTITY:
79
PERCENT COVERAGE:
32
Details for LemaA.01332.a.B1.GE34407
HARVESTED ON:
2/6/2012
SEQUENCED ON:
2/21/2012
EXPECTED MW:
36kDa
OBSERVED MW:
36kDa
ANTIBIOTIC MARKER:
ampicillin
COUNT OF EXPRESSION COLONIES:
Too many to count (100+)
TOTAL EXPRESSION LEVEL:
Low Expression
SOLUBLE EXPRESSION LEVEL
Moderate Expression
EXPRESSION HOST:
data unavailable
SEQUENCING RESULT:
pass with incomplete coverage
PERCENT IDENTITY:
99
PERCENT COVERAGE:
94
Details for LemaA.01332.a.AE1.PS38618
PURIFICATION DATe:
11/5/2019
CONCENTRATION:
87.42mg/ml
OBSERVED MW:
38kDa
EXPRESSION LEVEL:
Low Expression
PROTEIN PURIFICATION BUFFER:
SEC: 20 mM HEPES pH 7.0, 300 mM NaCl, 5% glycerol, 1 mM TCEP
EXPRESSION HOST:
BL 21 (DE3) Rosetta
VIAL COUNT (approx.):
4
VIAL VOLUME:
200µl
PERCENT IDENTITY:
79
PERCENT COVERAGE:
32
Details for LemaA.01332.a.AE1.PS38633
PURIFICATION DATe:
1/14/2020
CONCENTRATION:
13.16mg/ml
OBSERVED MW:
32kDa
EXPRESSION LEVEL:
Low Expression
PROTEIN PURIFICATION BUFFER:
SEC: 20 mM HEPES pH 7.0, 300 mM NaCl, 5% glycerol, 1 mM TCEP
EXPRESSION HOST:
BL 21 (DE3) Rosetta
VIAL COUNT (approx.):
5
VIAL VOLUME:
200µl
PERCENT IDENTITY:
79
PERCENT COVERAGE:
32
Details for LemaA.01332.a.B1.PW35017
PURIFICATION DATe:
3/19/2012
CONCENTRATION:
28.69mg/ml
OBSERVED MW:
35kDa
EXPRESSION LEVEL:
Moderate Expression
PROTEIN PURIFICATION BUFFER:
25 mM HEPES pH 7.0, 500 mM NaCl, 5% Glycerol , 2 mM DTT, and 0.025% Azide
EXPRESSION HOST:
data unavailable
VIAL COUNT (approx.):
10
VIAL VOLUME:
200µl
PERCENT IDENTITY:
99
PERCENT COVERAGE:
94